Cargando…
Genetic variants of NEUROD1 target genes are associated with clinical outcomes of small‐cell lung cancer patients
BACKGROUND: Neurogenic differentiation factor 1 (NEUROD1) is frequently overexpressed in small‐cell lung cancer (SCLC). NEUROD1 plays an important role in promoting malignant behavior and survival. METHODS: In this study, we evaluated the association between putative functional polymorphisms in 45 N...
Autores principales: | Lee, Sunwoong, Yoo, Seung Soo, Choi, Jin Eun, Hong, Mi Jeong, Do, Sook Kyung, Lee, Jang Hyuck, Lee, Won Ki, Park, Ji Eun, Choi, Sun Ha, Seo, Hyewon, Lee, Jaehee, Lee, Shin Yup, Cha, Seung Ick, Kim, Chang Ho, Kang, Hyo‐Gyoung, Park, Jae Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151137/ https://www.ncbi.nlm.nih.gov/pubmed/36935366 http://dx.doi.org/10.1111/1759-7714.14839 |
Ejemplares similares
-
Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell Lung Cancer
por: Yoo, Seung Soo, et al.
Publicado: (2023) -
Genetic Variants in Histone Modification Regions Predict Clinical Outcomes of Pemetrexed Chemotherapy in Lung Adenocarcinoma
por: Lee, Yong Hoon, et al.
Publicado: (2023) -
Genetic variants in key necroptosis regulators predict prognosis of non‐small cell lung cancer after surgical resection
por: Lee, Jang Hyuck, et al.
Publicado: (2023) -
Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma
por: Hong, Mi Jeong, et al.
Publicado: (2022) -
Effect of genetic variation in Notch regulator DTX1 on SCLC prognosis compared with the effect on NSCLC prongosis
por: Yoo, Seung Soo, et al.
Publicado: (2020)